Semax vs Selank: A Laboratory Research Comparison

Semax and Selank are frequently grouped together in cognitive-peptide catalogs, but they are distinct heptapeptides with different parent-sequence origins and different experimental literatures. Their shared C-terminal Pro-Gly-Pro motif is useful context—not evidence that the materials are interchangeable.

Semax vs Selank at a glance

The shared PGP motif does not make them the same peptide

Both common sequences contain seven amino-acid residues and end in Pro-Gly-Pro. That shared terminal motif helps explain why the names often appear in the same discussion, but the N-terminal tetrapeptides are different. Semax begins with Met-Glu-His-Phe, whereas Selank begins with Thr-Lys-Pro-Arg.

A four-residue difference is substantial for a seven-residue material. It changes molecular composition, exact mass, charge distribution, possible fragmentation behavior, and the literature that can be applied to the test article. A laboratory should record the full stated sequence rather than relying on the category label “cognitive peptide.”

What the Semax literature actually studies

Semax is commonly described in primary literature as ACTH(4–7)PGP. In a rat permanent middle cerebral artery occlusion model, Dmitrieva and colleagues analyzed expression of neurotrophins and their receptors after Semax or PGP exposure. The design is useful because it separates the full heptapeptide from the shorter terminal fragment and measures molecular endpoints in a defined animal model.

A separate in-vitro study examined Semax complex formation with copper(II) using equilibrium measurements and spectroscopy, then evaluated copper-associated cell toxicity in neuroblastoma and endothelial cell lines. This is a different experimental question from the transcriptomic work. It also illustrates why “what was measured” matters more than a broad catalog theme.

These studies establish research contexts for the specifically defined material. They do not authenticate a commercial sample, validate an unstated formulation, or provide a universal protocol.

What the Selank literature actually studies

Selank is commonly reported as Thr-Lys-Pro-Arg-Pro-Gly-Pro. One receptor-binding investigation used radioligand methods with rat-brain cell plasma membranes and examined how Selank affected tritiated GABA binding, including experiments involving other reference compounds. The authors described concentration-dependent modulation in that experimental system.

Another primary study used an unpredictable chronic mild stress model in rats and examined behavioral measures alongside diazepam-related experimental conditions. The methods, model, comparison groups, and endpoints differ sharply from the Semax ischemia and cell-based studies above.

Those differences are a reason to preserve separate literature maps. Results from one peptide or model should not be transferred to the other because both are discussed under the same broad research category.

A direct analytical comparison requires two reference identities

Vanhee and colleagues reported the detection of Semax and Selank in seized preparations and developed a combined liquid-chromatography tandem mass-spectrometry approach for a wider set of research peptides. Their work is especially relevant to catalog evaluation: a label name is not the same thing as analytical confirmation.

For a comparative analytical project, record the expected sequence and theoretical mass for each material, then determine whether the method distinguishes the intact analytes, relevant charge states, fragments, and possible degradation products. Retention time alone is not a complete identity argument unless it is tied to appropriate reference material and a validated method.

How to design a cleaner Semax vs Selank comparison

Product format, documentation, and stock are separate evidence layers

ELMNTPEP lists Semax and Selank as separate 10mg single-vial research products. Matching labeled amounts does not make the contents equivalent; it simply makes the catalog format easier to compare. Each listing carries its own product identity, current inventory state, price, and batch reference.

Use the testing documentation guide to review identity, method, result, specification, batch number, date, and report authorization. Testing documentation is available. Certificates of analysis will be posted to the site as they become available.

The research peptide storage and handling checklist provides a general chain-of-custody framework. Product-specific documentation should take precedence over generic assumptions, particularly when comparing two short peptides with different sequences.

Primary research references

• Dmitrieva et al. (2010) evaluated Semax and PGP in a rat cerebral-ischemia model using neurotrophin and receptor gene-expression endpoints.
• Tabbì et al. (2015) investigated Semax-copper(II) complex formation and copper-associated toxicity in two cell-line models.
• V’yunova et al. (2018) used radioligand receptor methods to investigate Selank-related modulation of GABA binding.
• Kasian et al. (2017) studied Selank in an unpredictable chronic mild stress model in rats.
• Vanhee et al. (2020) reported LC-MS/MS analysis of Semax, Selank, and other putative cognitive research peptides.

Explore every ELMNTPEP research comparison →

Research use notice: This article provides educational catalog, analytical, and literature context. It does not provide medical, dosing, administration, performance, or therapeutic guidance. ELMNTPEP products are intended for laboratory research use only and are not for human or veterinary consumption.